Skip to main content

Table 4 Unitary costs used in the study, updated to 2015-year value, and reported in $USPPP

From: Quality of life and cost-effectiveness analysis of topical tranexamic acid and fibrin glue in femur fracture surgery

 

Source

Published cost

Country

Publication year

2015-year value

2015 USPPP

Treatments

 Control

HSCSP

0.0

Spain

2015

0,0

0.0

 Topical TXA

HSCSP

8.6 €

Spain

2015

8.6 €

12.9

 FG

Corral 2016 [16]

399.1 $US

US

2016

399.1 $US

399.1

 Hospital stays

HSCSP

601.2 €

Spain

2015

601.2 $

916.5

Medical complications

 Blood transfusion (unit cost)

Darbà 2009 [15]

350.0 €

Spain

2009

395.3 $

591.7

 Wound infection

RECH

3191.0 €

Spain

2015

3191.0 $

4776.9

 Urinary tract infection

RECH

1448.0 €

Spain

2015

1448.0 $

2167.7

 Cardiac or respiratory failure

Allué 2014 [14]

11,107.0 €

Spain

2014

11,907.2 $

17,825.1

 Prostesis complications

Allué 2014 [14]

7024.0 €

Spain

2014

7530.0 $

11,272.5

 Surgical reintervention

RECH

9579.0 €

Spain

2015

9579.0 $

14,339.8

 Hematoma

Allué 2014 [14]

3498.0 €

Spain

2010

3750.0 $

5613.8

  1. HSCSP Financial Department of the Hospital de la Santa Creu and Sant Pau (Barcelona, Spain), RECH database of the Spanish Hospital Costs Network, USPPP $US Purchasing Power Parities are the rates of currency conversion that equalise the purchasing power of different currencies by eliminating the differences in price levels between countries, TXA Tranexamic Acid, FG Fibrin Glue, Euros, $ Dollar